How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Microsoft Corp. | €424.45 | €500.91 |
| Amazon.com Inc. | €240.50 | €258.42 |
| Alphabet Inc. C | €328.15 | €367.50 |
| Security | Price | Target price |
|---|---|---|
| Clorox Co. | €90.92 | €91.19 |
| Western Union Co. | €6.40 | €6.07 |
| Nike Inc. B | €36.22 | €64.16 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Axt Inc. | AlexanderDanielSchneider | 69.01% |
| B Bloom Energy Corp | JPMorgan Chase & Co. | 38.78% |
| B Coherent Corp. | PapaSmurf | 38.40% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Pantaflix AG | Vassago1 | -22.98% |
| S Apple Inc. | fenjal | -10.56% |
| S Pantaflix AG | blaugold | -8.90% |

sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Financial analysis of Broadridge
Broadridge Financial Solutions (BR.US) - FY2026 Annual Report
Broadridge appears to be experiencing a period of notably strong financial performance, with revenue reaching $7.48 billion and net income climbing to $1.12 billion. The company’s trajectory seems to be one of consistent expansion, with margins that have broadened steadily over the past five years.
The most striking development may lie in the profitability metrics. While revenue growth of 8.5% year-over-year reflects a healthy pace, the jump in net income of nearly 34% stands out, far outpacing revenue growth. This suggests significant operating leverage is being realized. The net margin expanded to over 15%, a considerable step up from the 12.2% seen just a year prior and from 9.4% in FY2022. This improvement appears to stem partly from modest operating margin gains, but a sharp swing in other non-operating income, which turned significantly positive, seems to have been a powerful contributor to the bottom-line surge. The reported return on equity of 39.6% is remarkably high, though it is notably amplified by a financial leverage ratio above 3x.
Portfolios of our members
D-wave Quantum Inc.
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Deep Sea Minerals Corp.
WKN: A420P7 / Name: Deep Sea Minerals Corp. / Stock / ? /
Pros
Cons
Palantir Technologies Inc.
WKN: A2QA4J / Symbol: PLTR / Name: Palantir Technologies / Stock / Large Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Perrigo Co. plc | €11.58 | 23.800% |
| Wynn Resorts Ltd | €93.50 | 10.510% |
| International Flavors & Fragrances Inc. | €75.62 | 7.780% |
| Newmont Mining Corp._INT | €90.89 | 7.230% |
| Newmont Corp. | €89.00 | 6.710% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Davita Inc. | €161.45 | -18.290% |
| Insulet Corp. | €118.60 | -18.010% |
| CDW Corp. | €116.70 | -12.720% |
| Lumen Technologies Inc. | €5.23 | -10.140% |
| Crown Castle Internatl Corp. | €62.00 | -8.150% |
Courses
sharewise Introduction
Key figures for stocks
Predictions
Top News
Lifecore Biomedical Q2 Earnings Call Highlights
Key Points
- Interested in Lifecore Biomedical, Inc.? Here are five stocks we like better.
- Lifecore reaffirmed its 2026 guidance for revenue of $120 million to $125 million and adjusted EBITDA of
Kaltura Q2 Earnings Call Highlights
Key Points
- Interested in Kaltura, Inc.? Here are five stocks we like better.
- Q2 results exceeded guidance: Revenue rose 5% year over year to $46.9 million, subscription revenue increased 8% to
Geron Q2 Earnings Call Highlights
Key Points
- Interested in Geron Corporation? Here are five stocks we like better.
- Geron reported strong second-quarter performance, with revenue rising 17% year over year to $57.5 million and
1stdibs.com Q2 Earnings Call Highlights
Key Points
- Interested in 1stdibs.com, Inc.? Here are five stocks we like better.
- Q2 results exceeded guidance: GMV rose 7% year over year to $96 million and revenue increased 5% to $23.3
Bloomin' Brands Q2 Earnings Call Highlights
Key Points
- Interested in Bloomin' Brands, Inc.? Here are five stocks we like better.
- Q2 results improved: Revenue rose 1% to $1.02 billion, while adjusted EPS increased to $0.39 from $0.32
Finanzmärkte im Wandel und wie neue digitale Dynamiken Investoren beeinflussen
XPEL, Inc. (XPEL) Q2 Earnings and Revenues Top Estimates
XPEL, Inc. (XPEL) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.59 per share a year ago. These figures
Vishay Intertechnology (VSH) Q2 Earnings Beat Estimates
Vishay Intertechnology (VSH) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to a loss of $0.07 per share a year ago
TeraWulf Inc. (WULF) Reports Q2 Loss, Beats Revenue Estimates
TeraWulf Inc. (WULF) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.05 per share a year ago. These figures are
Valvoline (VVV) Q3 Earnings and Revenues Surpass Estimates
Valvoline (VVV) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.47 per share a year ago. These figures
Spire (SR) Reports Q3 Loss, Beats Revenue Estimates
Spire (SR) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to earnings of $0.01 per share a year ago. These figures are
News
Compass Pathways Q2 Earnings Call Highlights
Key Points
- Interested in Compass Pathways PLC Sponsored ADR? Here are five stocks we like better.
- Compass Pathways remains on track to file for FDA approval of COMP360 for treatment-resistant
Acacia Research Q2 Earnings Call Highlights
Key Points
- Interested in Acacia Research Corporation? Here are five stocks we like better.
- Q2 revenue more than doubled to $114.6 million from $51.2 million a year earlier, supported by IP
Aurora Cannabis Q1 Earnings Call Highlights
Key Points
- Interested in Aurora Cannabis Inc.? Here are five stocks we like better.
- International medical cannabis drove growth: Revenue rose to C$67.6 million, with international medical
ElringKlinger Q2 Earnings Call Highlights
Key Points
- Interested in ElringKlinger AG? Here are five stocks we like better.
- Revenue rose 17% year over year to €479 million in Q2 2026, while adjusted EBIT increased 19% to €28.9 million
Klöckner & Co SE Q2 Earnings Call Highlights
Key Points
- Interested in Klöckner & Co SE? Here are five stocks we like better.
- Q2 EBITDA before special effects reached €63 million, placing Klöckner & Co in the upper half of its €170
Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Tops Revenue Estimates
Entrada Therapeutics, Inc. (TRDA) came out with a quarterly loss of $1.01 per share versus the Zacks Consensus Estimate of a loss of $1.16. This compares to a loss of $1.04 per share a year ago
SharkNinja, Inc. (SN) Q2 Earnings and Revenues Top Estimates
SharkNinja, Inc. (SN) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $0.97 per share a year ago. These
TAT Technologies Ltd. (TATT) Q2 Earnings and Revenues Beat Estimates
TAT Technologies Ltd. (TATT) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.3 per share a year ago
Gibraltar Industries (ROCK) Beats Q2 Earnings and Revenue Estimates
Gibraltar Industries (ROCK) came out with quarterly earnings of $1.11 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $1.13 per share a year ago
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobieren
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.










